HIV/AIDS Vaccine
Antibody responses elicited by HIV glycoproteins are characterized
Published in AIDS Weekly, March 20th, 2006
According to recent research from the United States and Belgium, "We previously reported that soluble, stable YU2 gp140 trimeric human immunodeficiency virus type I (HIV-1) envelope glycoprotein immunogens could elicit improved breadth of neutralization against HIV-1 isolates compared to monomeric YU2 gp120 proteins. In this guinea pig immunization study, we sought to extend these data and determine if adjuvant could quantitatively or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-03-20)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Genotypic and phenotypic clinical cut-off levels determined for ritonavir-boosted saquinavir - HIV/AIDS Drug Resistance
Infant-only prophylaxis eliminates nevirapine resistance development in mothers and infants - HIV/AIDS Pharmacokinetics
Interpatient variability in plasma efavirenz levels determined by gender and race - HIV/AIDS Transmission
Cell reservoirs in lymph nodes infected with HIV-1 subtype E differ from subtype B - Pediatrics HIV/AIDS Risk Factors
Infants perinatally infected with HIV at risk from BCG vaccination - Business Update
Blood safety scientific advisory board established by Cerus - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
